ProfileGDS4718 / 203326_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 69% 67% 72% 69% 66% 65% 71% 71% 69% 67% 68% 68% 66% 65% 67% 69% 70% 68% 75% 69% 66% 68% 68% 69% 68% 66% 67% 70% 69% 68% 65% 73% 70% 67% 64% 70% 68% 68% 65% 68% 71% 65% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6188567
GSM549102patient 115, normal, homogenized [OPG study]6.7463169
GSM549104patient 119, normal, homogenized [OPG study]6.7075367
GSM549108patient 138, normal, homogenized [OPG study]6.9788172
GSM549119patient 077, normal, homogenized [OPG study]6.7712969
GSM549133patient 032, cancer, homogenized [OPG study]6.5939266
GSM549139patient 042, cancer, homogenized [OPG study]6.5051665
GSM549099patient 107, normal, homogenized [OPG study]6.9102271
GSM549109patient 139, normal, homogenized [OPG study]6.9537971
GSM549110patient 046, normal, homogenized [OPG study]6.7948769
GSM549114patient 063, normal, homogenized [OPG study]6.6260567
GSM549122patient 082, normal, homogenized [OPG study]6.7479968
GSM549134patient 033, cancer, homogenized [OPG study]6.7019768
GSM549136patient 036, cancer, homogenized [OPG study]6.5520266
GSM549140patient 044, cancer, homogenized [OPG study]6.4878165
GSM549111patient 047, normal, homogenized [OPG study]6.678567
GSM549113patient 057, normal, homogenized [OPG study]6.7689369
GSM549132patient 031, cancer, homogenized [OPG study]6.92370
GSM549137patient 038, cancer, homogenized [OPG study]6.7458268
GSM549142patient 047, cancer, homogenized [OPG study]7.2525375
GSM549100patient 110, normal, homogenized [OPG study]6.7285169
GSM549107patient 135, normal, homogenized [OPG study]6.5196566
GSM549115patient 068, normal, homogenized [OPG study]6.7422968
GSM549116patient 072, normal, homogenized [OPG study]6.7400968
GSM549120patient 078, normal, homogenized [OPG study]6.7712769
GSM549131patient 030, cancer, homogenized [OPG study]6.7285168
GSM549118patient 074, normal, homogenized [OPG study]6.5847966
GSM549129patient 027, cancer, homogenized [OPG study]6.6910767
GSM549123patient 088, normal, homogenized [OPG study]6.9097670
GSM549124patient 006, cancer, homogenized [OPG study]6.7430869
GSM549126patient 015, cancer, homogenized [OPG study]6.6665368
GSM549128patient 025, cancer, homogenized [OPG study]6.4892665
GSM549103patient 117, normal, homogenized [OPG study]7.023573
GSM549117patient 073, normal, homogenized [OPG study]6.8141270
GSM549138patient 041, cancer, homogenized [OPG study]6.6471867
GSM549141patient 045, cancer, homogenized [OPG study]6.4668264
GSM549130patient 028, cancer, homogenized [OPG study]6.8248570
GSM549101patient 111, normal, homogenized [OPG study]6.7144868
GSM549105patient 128, normal, homogenized [OPG study]6.742868
GSM549106patient 134, normal, homogenized [OPG study]6.4696365
GSM549112patient 048, normal, homogenized [OPG study]6.7179868
GSM549125patient 011, cancer, homogenized [OPG study]6.9203571
GSM549127patient 024, cancer, homogenized [OPG study]6.5708265
GSM549135patient 035, cancer, homogenized [OPG study]6.4053664